Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts

作者：Saini Deepti; Weber Joseph; Ramachandran Sabarinathan; Phelan Donna; Tiriveedhi Venkataswarup; Liu Michael; Steward Nancy; Aloush Aviva; Hachem Ramsey; Trulock Elbert; Meyers Bryan; Patterson G Alexander; Mohanakumar Thalachallour^*

来源：Journal of Heart and Lung Transplantation, 2011, 30(6): 624-631.

DOI：10.1016/j.healun.2011.01.708

• alloimmunity
• autoimmunity
• chronic rejection
• donor specific antibodies
• lung transplantation

BACKGROUND: Bronchiolitis obliterans syndrome (BUS) is a major cause of morbidity and mortality after lung transplantation (LTx). We sought to better understand the relationship between alloimmune responses and autoimmunity and, subsequently, how autoimmunity leads to chronic rejection.
METHODS: We analyzed the development of donor-specific antibodies (Abs) in LTx by flow PRA and the development of Abs to K-alpha 1 tubulin (K-alpha 1T) and collagen V (ColV) by ELISA. The frequency of K-alpha 1T-and Co1V-specific T cells that secrete IFN-gamma, IL-17 and IL-10 in LTx recipients was measured by ELISPOT.
RESULTS: In a retrospective analysis of 42 LTx recipients, we demonstrated a strong correlation between development of donor-specific anti-HLA Abs, Abs to self-antigens and BOS (p < 0.05). To test the hypothesis that alloimmunity is related to an immune response to self-antigens, we analyzed 103 LTx patients prospectively for the development of donor-specific Abs (DSA) and Abs to self-antigens. A total of 42.7% of recipients developed DSA and 30.1% developed Abs to K-a IT and ColV. Development of DSA preceded development of Abs to self-antigens. BOS(+) patients had higher frequency of T cells secreting IL-17 (p < 0.01) and IFN-gamma (p < 0.05) with decreased IL-10 (p < 0.05) when compared with BOS(-) patients.
CONCLUSIONS: Based on these results we propose that alloimmune responses to donor HLA can induce autoimmune responses to airway epithelial self-antigens, characterized by activation of the IL-17 pathway. These immune responses to self-antigens along with alloimmunity contribute to the pathogenesis of BOS. Strategies to prevent development of autoimmunity may be play a key role in preventing the development of chronic rejection.

• 出版日期2011-6